Constellation Brands’ Stock: Ratings after Q3 Results
As of January 6, 67% or 12 out of 18 analysts covering Constellation Brands’ (STZ) had a “buy” recommendation.
Constellation Brands’ (STZ) 12-month forward PE (price-to-earnings) ratio fell 7.3% to 20.1x on January 5, following the company’s fiscal 3Q17 results.
Constellation Brands’ (STZ) Wine and Spirits segment accounted for 46.7% of the company’s fiscal 3Q17 sales.
Conagra’s Valuation after Its 3Q17 Earnings
As of March 24, 2017, Conagra Brands (CAG) was trading at a 12-month forward PE (price-to-earnings) ratio of 21.9x.
About 64.0% of analysts covering Conagra (CAG) have recommended a “buy” for the stock, and 29.0% have recommended a “hold.”
Conagra Brands’ (CAG) adjusted gross margin expanded in fiscal 3Q17, despite lower sales and gross profit dollars.
General Mills’ Revenue: Lower than Analysts’ Estimates
In fiscal 3Q17, General Mills posted revenue of $3.79 billion—a fall of 5.2% from $4 billion in fiscal 3Q16.
General Mills (GIS) reported its fiscal 3Q17 earnings on March 21, 2017. The results are for a three-month period ending on February 26, 2017.
General Mills (GIS) plans to announce its fiscal 3Q17 results on March 21, 2017. The company’s management lowered its EPS growth guidance to 5%–7% from its earlier guidance of 6%–8%.
How Target’s Valuation Looks Now
On March 20, Target was trading at a 12-month forward PE ratio of 13.6x—lower than the S&P 500 Index’s (SPX) PE ratio of 18.8x.
Of the 28 analysts covering Target (TGT) stock, 22.0% have rated the stock as a “buy” as of March 20. Target stock has been rated as a “hold” by 64%.
Target (TGT) has a strong track record of rewarding investors with higher dividends and share repurchases.
Why Monster Beverage Is Trading at a Premium Valuation to Peers
As of March 3, 2017, Monster Beverage (MNST) was trading at a 12-month forward PE ratio of 31.5x. Its valuation multiple rose 12.5% on March 2, 2017.
On March 3, 2017, 13 of the 17 analysts (or 76.0%) covering Monster Beverage (MNST) stock gave it a “buy” recommendation. Four analysts gave it a “hold.”
Monster Beverage (MNST) delivered net sales of $753.8 million in 4Q16, which was significantly above the consensus analyst sales estimate of $722.5 million.
Wall Street Optimistic on Walgreens ahead of Fiscal 2Q17 Results
Walgreens Boots Alliance (WBA) is currently trading at $83.56 as of March 27, 2017, which is ~5.3% below its 52-week high.
Earnings growth was mainly driven by WBA’s partnerships with pharmacy benefit managers and insurance companies and from cost control initiatives.
In fiscal 1Q17, WBA’s total sales fell 1.8% YoY to $28.5 billion, missing the consensus for the fifth consecutive quarter.